• Thursday 31 May 2018
  • Scientific Session 3
    • 08:00
      Endothelial Cell Lineage Tracing in Cerebral Cavernous Malformations: A Modification of the “Two-Hit” Mutation Model of CCM Pathogenesis.

      Matthew Detter and Douglas Marchuk
    • 08:09
      Rapamycin not shown to inhibit LM growth in a mouse xenograft model.

      Tony Penington, Zerina Lokmic and Nerida Sleebs
    • 08:18
      Activation Of AKT In Tissue Endothelial Cells & Elevated Serum ANG-2 levels in Patients With Capillary Lymphatic Venous Malformations

      Tim LeCras, Jillian Goines, patricia pastura, Paula Mobberley-Schuman, Megan Metcalf, Denise Adams, Adrienne Hammill and Elisa Boscolo
    • 08:27
      Laser Ablation of Lymphatic Malformation Using Nanoparticle Targeted Therapy

      Ravi Sun, Ekaterina Galanzha, Dmitry Nedosekin, Haihong Zhang, Ting Wei, Zerina Lokmic, June Wu, Tony Penington, Vladimir Zharov and Gresham Richter
    • 08:36
      Excessive PI3K/mTOR signaling causes lymphatic hyperplasia and dysfunction in mice

      Devon Hominick, Noor Khurana, Lara Rodriguez-Laguna, Noelia Agra, Gema Gordo, Pablo Lapunzina, Juan C. Lopez-Gutierrez, Victor Martinez-Glez and Michael Dellinger
    • 08:41
      Superficial Cutaneous Vascular Malformations and Other Skin Manifestations of the PIK3CA-Related Overgrowth Spectrum (PROS)

      Justine Pasteur, Paul Kuentz, Yannis Duffourd, Arthur Sorlin, Laurence Faivre, Christelle Thauvin, Jean-Baptiste Rivière, Pierre Vabres and Investigators of MUSTARD Cohort
    • 08:48
      The full spectrum of post-zygotic PIK3CA mutations in non-syndromic lymphatic malformations

      James Bennett, Chi Cheng, Dana Jensen, Andrew Timms, Sheila Ganti, Giri Shivaram, Randall Bly, Andrew Kirsh, William Dobyns, Mark Makesky and Jonathan Perkins
    • 08:57
      Activating mutations in PIK3CA are specifically localized in lymphatic malformation-derived lymphatic endothelial cells of young children: therapeutic implications

      Jochen Rössler, Hannah Blesinger, Juergen Becker, Silke Kaulfuss and Jörg Wilting
    • 09:04
      Safety and Efficacy of Low Dose Sirolimus in Patients with PIK3CA-Related Overgrowth

      Victoria Parker, Kim M. Keppler-Noreuil, Pierre Vabres, Leena De Silva, Julie C. Sapp, Maxime Luu, Marjorie J. Lindhurst, Elodie Gautier, Marc Bardou, Laurence Faivre, Robert Semple and Leslie G. Biesecker
    • 09:13

      Vittoria Baraldini
    • 09:20
      “PTEN hamartoma of soft tissue” may also be related to PIK3CA mutations.

      Olivia Boccara, Louise Galmiche-Rolland, Bérengère Dadone, Stéphanie Pannier, Véronique Soupre, Florence Pedeutour and Sylvie Fraitag
    • 09:27
      How to build a multi-disciplinary vascular anomalies clinic from scratch: Lessons learned from a large, tertiary-care American children’s hospital

      C. Matthew Hawkins, Steven Goudy, Michael Briones, Rachel Swerdlin, Jonathan Meisel, Sarah Milla, Magdalena Soldanska and Leslie Lawley
    • 09:36
      A FAIR compliant registry for the vascular malformation centres within the European Reference Networks. How it was done

      Leo Schultze Kool, Alan IRVINE, Päivi Salminen, Nader Ghaffarpour, Andrea Diociaiuti, Jochen Rössler, C.T. van den Bosch, Eulalia Baselga, Anne Dompmartin, Laurence Boon, Miikka Vikkula, Luiz Bonino, Mark Thompson, Annika Jacobsen, David van Enckevort and Marco Roos
    • 09:45
      The European Reference Network (ERN) criteria for multidisciplinary vascular anomaly clinics (VASCA) in the VASCERN

      Jochen Rössler, Eulalia Baselga, Laurence Boon, Andrea Diociaiuti, Anne Dompmartin, Nader Ghaffarpour, Alan D Irvine, Paivi Salminen, Leo SchultzeKool, Caroline van den Bosch and Miikka Vikkula
    • 09:54
      Patient involvement on vascular anomalies in the European Reference Network VASCERN

      C.T. van den Bosch, Matt Bolz-Johnson, Miikka Vikkula, Leo Schultze Kool, Jochen Rössler, Eulalia Baselga, Laurence Boon, Andrea Diociaiuti, Anne Dompmartin, Nader Ghaffarpour, Alan Irvine, Päivi Salminen, Maria Barea, Ange van der Velden and Petra Borgar
  • 10:00
    Coffee Break
  • Difficult Cases 2
    • 10:30
      Syndromic segmental arterio-venous malformation: a therapeutic challenge

      Olivia Boccara, Annouk Bisdorff Bresson, Diala Khraiche, Olivier Naggara, Timothée de Saint-Denis, Paul Kuentz, Smail Hadj-Rabia, Francis Brunelle and Stéphanie Pannier
    • 10:39
      A difficult case of upper limb venous malformation with intolerance to oral sirolimus

      Mei-Yoke Chan, Luke Toh and Mark Koh
    • 10:48
      Management challenges of a complex CLOVES Syndrome patient with severe scoliosis and lipomatous overgrowth

      Wesley Barry, Donna Nowicki, Minnelly Luu, Chadi Zeinati, Lori Howell and Dean Anselmo
    • 10:57
      Case Report: Management of Menorrhagia in a Young Woman with Blue Rubber Bleb Nevus Syndrome: Failures and Successes

      Carrie Terrell, Sheilagh Maguiness and Brenda Weigel
  • Scientific Session 4
    • 11:10
      Ethylene vinyl alcohol copolymer in the treatment of high flow arteriovenous vascular malformations: Long- term results and histology

      Antoinette Gomes, Phillip Monteleone, Alison Vasan , James Sayre and Susan Bukata
    • 11:19

      Jean Nicolas Racicot, Josee Dubois, Patrick Gilbert, Patricia Bortoluzzi, Julie Powell, Alain Danino, Marie-France
    • 11:28

      Minia Campos-Domínguez, Víctor Martínez-Glez, Verónica Seidel, Teresa Martínez-Menchón, Belén Ferri Ñiguez, Antonio Cervantes Pardo, Ángel Lancharro-Zapata, Yolanda Ruiz-Martín, Antonio Salcedo-Posadas, Jorge Huerta-Aragonés, Carmen Garrido-Colino, Beatriz Berenguer-Fröhner, Elena De Tomás-Palacios, Concepción Lorca-García and Rosario García-Pajares
    • 11:35
      Somatic MAP2K1 Mutations are Associated with Extracranial Arteriovenous Malformation, Constitutively Activate the RAS/MAPK Pathway, and are Enriched in Blood Vessels in Patients with Arteriovenous Malformations

      Jeremy Goss, Javier Couto, Patrick Smits, Mohammed Alomari, Yue Huang, Dennis Konczyk, Steven Fishman, John Mulliken, Matthew Warman and Arin Greene
    • 11:45
      Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy

      Satyamaanasa Polubothu, Mary Glover, Lara Al-Olabi, Katherine Dowsett, Katrina Andrews, Paulina stadnik, Agnel P Joseph, Rachel Knox, Alan Pittman, Graeme Clark, William Baird, Neil Bulstrode, Kristiana Gordon, Darren Hargrave, Sue Huson, Thomas Jacques, Gregory James, Hannah Kondolf, Loshan Kangesu, Kim Keppler-noreuil, Amjad Khan, Marjorie Lindhurst, Mark Lipson
    • 11:54
      The Role of Notch Pathway Components in Extracranial Arteriovenous Malformations

      Ting Wei, Haihong Zhang, Ravi Sun and Gresham Richter
  • 12:02
    Lunch & Poster Viewing
  • Scientific Session 5
    • 13:30
      Source of Elevated AFP Levels in Infantile Haemangioma

      Tinte Itinteang, Matthew Munro, Bede van Schaijik, Jennifer de Jongh, Erin Paterson, Reginald Marsh and Swee Tan
    • 13:37
      Resistance Index (RI) in Colour Coded Duplex Sonography (CCDS) Easy Use and Reliable Results in the Determination of Activity in Infantile Hemangiomas

      Peter Urban
    • 13:44

      Maria Cossio, Josee Dubois, Catherine McCuaig, Danielle Marcoux, Sandra Ondrejchak and Julie Powell
    • 13:51
      Tardive Expansion Congenital Hemangioma: a variation of NICH or a new hemangiomatous entity?

      Chen Hua, Yunbo Jin, Lizhen Wang, Hui Chen, Gang Ma, Yajing Qiu and Lin Xiaoxi
    • 13:58
      Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas

      Carine Van der Vleuten and Andre Moyakine
    • 14:07
      Multiple cutaneous and visceral GLUT-1 positive congenital vascular tumors: a novel entity or a variant of multifocal infantile hemangiomatosis.

      Esperanza Mantilla-Rivas, Pamela Tan, Jocelyn C Zajac, Alexandra Tilt, Nancy Bauman, Philip Guzzetta, Gina Krakovsky, Bhupender Yadav, Ana Yasmine Kirkorian and Albert Oh
    • 14:14
      Systemic Timolol Exposures Following Topical Application to Infantile Hemangiomas

      Beth Drolet, Felix Boakye-Agyeman, Sarah Chamlin, Scott Denne, Anita Haggstrom, Barrie Harper, Kristen Holland, Jan Hau Lee, Hui Min Liew, Andrew Lewandowski, Casey Gelber, Anthony Mancini, Dawn Siegel, Nicole Stefanko, Rami Yogev and Chiara Melloni
    • 14:23
      Efficacy and Safety of Topical Timolol Maleate 0.5% Solution for Infantile Hemangioma in Early Proliferative Phase. A Randomized Clinical Trial

      Fania Muñoz Garza, Mónica Ríos Varela, Esther Roé Crespo, Lluis Puig Sanz, José Bernabeu Wittel and Eulalia Baselga Torres
    • 14:32
      Utility of Prolonged Monitoring During Initiation of Oral Propranolol for Infantile Hemangioma

      Leanna Hansen, Denise Adams, Eulalia Baselga Torres, Sarah Chamlin, Kristen Corey, Flora Frascari, Ilona Frieden, Peter Frommelt, Eloise Galligan, Maria Garzon, Kimberly Horii, Justyna Klajn, Christine Lauren, Anthony Mancini, Diana Mannschreck, Erin Math
    • 14:39
      AQP1 plays a key role in propranolol response in vivo

      Francois Moisan, Priscilla Kaulanjan, Sorilla Prey, Maya Loot, Christine Léauté Labreze, Alain Taieb and Hamid Rezvani
    • 14:46
      Propranolol treatment does not affect growth and development of children with infantile hemangioma

      Andre Moyakine
    • 14:53
      Hemangioma Sequelae In Infantile Hemangiomas Treated With Propranolol

      Eulalia Baselga, may el hachem, Andrea Diociaiuti, Claudia Carnevale, Camila Downey, Esther Roe, Iria Neri, Miriam Leuzzi, Jose Bernabeu-Wittel, M Teresa Montserrat-Garcia, Alejandro Ortiz-Prieto, antonio torrelo, Nicole Knopfel, Nadia Vercellino, Francesca Manunza, M Antonia Gonzalez-Enseñat, M Asuncion Vicente-Villa and ignasi Gich
    • 15:00
      The positive predictive value of hemangioma location for risk of PHACE syndrome: a retrospective analysis

      Colleen Cotton, Jusleen Ahluwalia, Ilona Frieden, Leslie Castelo-Soccio, Elena Pope, Dawn Siegel, Esteban Fernandez-Faith, Kim Morel, Christine Lauren, Maria Garzon, Anthony Mancini, Sarah Chamlin, Anita Haggstrom, Megha Tollefson, Marilyn Liang, Sharon G
    • 15:07
      Sternal/Midline Anomalies in PHACE Syndrome

      Nicole Stefanko, Beth Drolet, Olayemi Sokumbi, Ilona Frieden, Renee Howard, Juan Carlos Lopez Gutierrez, Maria Garzon, Eloise Galligan, Denise Metry, Francine Blei, Janet Fairley, Deborah Goddard and Dawn Siegel
  • 15:15
    Coffee Break
  • Difficult Cases 3
    • 15:45
      Necrotizing Infection of an Infantile Hemangioma: An Uncommon Complication of a Common Disorder

      Bridget Shields, Lauren Brin Hermans, Beverly Aagaard-Kienitz, David Wargowski, Darya Buehler, Jason Pinchot, Carrie Kovarik, Lisa Arkin and Catharine Garland
    • 15:54
      Primary Hepatic Angiosarcoma in a 3 year-old Child Complicated by Consumptive Hypothyroidism: A Case Report

      Lara Mrak, Michael Woods, Carol Diamond, Jason Pinchot, Beverly Aagaard Kienitz, Lisa Arkin, Paula North, Darya Buehler and Kara Gill
    • 16:03
      Controversy RICH or KHE? What constitutes a true Kasabach Merritt syndrome? Necrotizing fasciitis in vascular anomalies: Seeking other centers experience, prevention?

      Catherine McCuaig, Michele David, Patricia Bortoluzzi, Louise Laberge, Elizabeth Rousseau, Afshin Hatami, Sandra Ondrejchak and Josée Dubois
    • 16:12
      Fatal hemorrhage from a rapidly involuting congenital hemangioma in an infant

      Aicha Salhi, Warda Drali, Nora Cheddani, Toufik Tounsi, Assya Djeridane, Abdelhamid Aitbenamar, Zoheir Belkaid and Ismail Benkaidali
  • 19:00
    Social Event - Congres Dinner